Coverage of the breakout session, facilitated by Ms. Myers, on personalized medicine at the Food and Drug Law Institute’s 53rd annual conference.
“FDA Aims For Flexibility In Upcoming Drug/Companion Diagnostic Guidance”
The Pink Sheet
(subscription required)